Whole-genome sequencing performed for human cancer research can contain informative microbial reads that are not part of the human reference genome. A study published October 20 in npj Biofilms and Microbiomes shows how carefully reanalysing those reads can recover bacterial genomes from a dataset originally assembled for prostate cancer genomics.
The investigators examined sequencing information from the PanProstate Cancer Group and selected 247 samples for metagenomic assembly after identifying candidate bacterial signals. Their workflow reconstructed 249 bacterial genomes with high estimated completeness, predominantly from oral-associated material. The analysis also identified bacterial lineages that lacked confident species-level classification, illustrating the limits of existing reference databases.
This approach makes use of material that may otherwise be discarded during host-focused alignment. It can expand microbial reference resources and generate hypotheses about which organisms are present in saliva, blood or tumour-associated samples. But low microbial biomass creates a substantial interpretation problem: reagent contaminants, environmental background and cross-sample contamination can resemble genuine biological signals. The mere recovery of a microbial genome from sequencing data does not prove tissue colonization.
The authors' computational strategy illustrates the importance of separating human and non-human reads, applying assembly and binning quality metrics, and checking reconstructed genomes for contamination and taxonomic consistency. Comparisons between sample types also require attention to how specimens were collected and processed. A microbial signal from saliva should not be casually generalized to prostate tissue.
For cancer researchers, the study is a resource-discovery effort rather than a demonstration that bacteria initiate or accelerate prostate cancer. For bioinformatics services, it provides a concrete example of how existing WGS datasets can be repurposed while preserving strict provenance and quality-control standards. Independent laboratory confirmation would be required before considering any recovered organism a diagnostic biomarker.